Dr Geoff Isbister
Senior Research Academic
School of Medicine and Public Health
EditCareer Summary
Qualifications
- Doctor of Medicine, University of New South Wales
- Bachelor of Science, University of New South Wales
- Bachelor of Medicine & Surgery, University of New South Wales
Research
Research keywords
- Clinical Toxicology
- Clinical Toxinology
- Emergency Medicine
- Pharmacokinetics and pharmacodynamics
- Toxinology
Research expertise
Dr Isbister is a clinician researcher in clinical toxicology and his research has focused on understanding poisoning and envenoming in patients and undertaking studies to determine the effectiveness of antidotes and antivenoms in treatment of these conditions. He has published over 140 original research publications and holds a second NHMRC Clinical Career Development Award. The benefits of the research include improving our understanding of the pathophysiology of both envenomation and poisoning. Much of his research challenges long held views about the treatment of poisoned and envenomed patients, including whether antivenom works. He has made clinicians re-look at what evidence there is for various treatments and why we use these treatments.
His first study of spider bite showed that the majority of spider bites cause minor effects, and the major effects only occurred with funnel-web spider bites and redback spider bites. The research also debunked the myth of the Whitetail Spider, showing that severe ulceration of the skin was due to a variety of causes but not spider bite. Other studies of bites and stings by venomous creatures, including scorpions, insects, marine animals and continues with snake bites in a national snake bite study formed the basis of his Doctor of Medicine titled: Data collection in clinical toxinology: debunking myths and developing diagnostic approaches to bites and stings
Ongoing major areas of research include:
1) Clinical Toxinology: observational and interventional studies in envenomed patients; this includes the Australian Snakebite Project ASP. The study has changed the way antivenom is dosed, decreasing the dose used and demonstrating the efficacy of antivenom. This study continues now investigating other treatments for snake bite and is funded by the NHMRC. A similar study has commenced in Sri Lanka in 2005 and has recently received NHMRC funding. The clinical toxinology laboratory based at the Calvary Mater Newcastle undertakes assays for venoms, toxins and antivenom in human blood, with very low limits of detection allowing their use in clinical and forensic cases. The Redback Spider Antivenom Evaluation (RAVE) Study, funded by the NHMRC is investigating the effectiveness of redback spider antivenom for the treatment of pain and systemic effects. A previous study established hot water as a safe and easily applied treatment for blue bottle stings which changed the Australian Resuscitation Councils recommendations on the first aid treatment and was awarded the Medical Journal of Australia and Wyeth Australia award for best research published in the journal in 2006.
2) Modelling and simulation in toxicology: This is multicentre research into the pharmacokinetics and pharmacodynamics of drugs in overdose with patient blood samples and clinical data to develop clinical guidelines for treatment using novel drug modeling and simulation techniques. These studies of treatments for drug overdose have rationalized the treatment for particular drug overdoses streamlining the care for patients. This includes research into the effects of drugs on the electrocardiogram and the effect on the QT interval which is associated with fatal arrhythmias, developing a risk assessment tool (QT nomogram). Other projects include prospective studies of overdose patients and the relative toxicity of psychotropic medications, and one of these publications is now highly cited comparing the newer antidepressants toxicity. There is ongoing research on serotonin toxicity and a study that developed new diagnostic criteria for serotonin toxicity. This work has changed our understanding and approach to the treatment of serotonin toxicity over the last 5 years.
3) Acute behavioural Disturbance: Recent research has been commenced on the sedation of violent and aggressive patients in the health care setting, with a focus on drug and alcohol induced delirium in the emergency department.
Fields of Research
| Code | Description | Percentage |
|---|
| 110299 | Cardiovascular Medicine And Haematology Not Elsewhere Classified | 45 |
| 111500 | Pharmacology And Pharmaceutical Sciences | 35 |
| 111799 | Public Health And Health Services Not Elsewhere Classified | 20 |
Appointments
Fellowship National Health & Medical Research Council (Australia) | 01/01/2010 |
Teaching
Teaching keywords
- Clinical Toxicology
- Clinical Toxinology
- Emergency Medicine
Teaching expertise
Clinical pharmacology, clinical toxicology and emergency medicine to undergraduates and post-graduates.
EditPublications
No publications.
EditGrants and Funding
Summary
| Number of grants | 22 |
|---|
| Total funding | $5,128,067 |
|---|
For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.
- Indicates that the researcher may be seeking students for this project.
Click on a grant title below to expand the full details for that specific grant.
2012 (3 grants)
A novel approach to snakebite first aid$195,721
Funding Body: NHMRC (National Health & Medical Research Council)
First Aid for Cytotoxic Snakebite$25,000
Funding Body: Hunter Medical Research Institute
Biomarkers of acute renal toxicity in humans$10,000
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team |
|---|
| Professor Nicholas Buckley, Professor Zoltan Endre, Professor Andrew Dawson, Professor Rezvi Sheriff, Doctor Geoff Isbister, Professor Michael Roberts |
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $10,000 | 2012 | 2013 |
| GNo:G1100879 |
2011 (2 grants)
Biomarkers of acute renal toxicity in humans$1,044,710
Funding Body: NHMRC (National Health & Medical Research Council)
| Scheme | Role |
|---|
| Project Grant | Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $1,044,710 | 2011 | 2013 |
| GNo:154550506 |
A randomised controlled trial of antivenom for red-bellied black snake envenoming$445,576
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team |
|---|
| Doctor Geoff Isbister, Professor Nicholas Buckley |
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $445,576 | 2011 | 2014 |
| GNo:G1000301 |
2010 (4 grants)
Does fresh frozen plasma in Russells viper bite coagulopathy reduce the dose and duration of antivenom therapy?$600,500
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team |
|---|
| Doctor Geoff Isbister, Professor Nicholas Buckley, Professor Janaka de Silva, Conjoint Professor Andrew Dawson, Assoc. Prof David Lalloo |
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $600,500 | 2010 | 2012 |
| GNo:G0190172 |
Multicentre studies of interventions in clinical toxicology and envenoming, including antivenoms and decontamination $417,000
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team |
|---|
| Doctor Geoff Isbister |
| Scheme | Role |
|---|
| Career Development Fellowships | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $417,000 | 2010 | 2013 |
| GNo:G0900229 |
Randomised controlled trial of intravenous antivenom versus placebo in the treatment of red back spider bite$148,772
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team |
|---|
| Doctor Geoff Isbister, Associate Professor Simon Brown |
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $148,772 | 2010 | 2011 |
| GNo:G0900241 |
. Evaluation of the kinetics of blood clotting for assessing enoxaparin activity$12,000
Funding Body: University of Otago
| Scheme | Role |
|---|
| Research Grant | Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $12,000 | 2010 | 2011 |
| GNo:154550578 |
2009 (1 grants)
Randomised controlled trial of intravenous antivenom versus placebo in the treatment of redback spider bite$300,000
Funding Body: NHMRC (National Health & Medical Research Council)
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $300,000 | 2009 | 2010 |
| GNo:154550586 |
2008 (1 grants)
A randomised controlled trial of factor replacement therapy in snake bite coagulopathy$689,500
Funding Body: NHMRC (National Health & Medical Research Council)
| Scheme | Role |
|---|
| Project Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $689,500 | 2008 | 2010 |
| GNo:154550514 |
2007 (3 grants)
Mediators in Anaphylaxis$350,000
Funding Body: Food and Allergy Network
| Scheme | Role |
|---|
| United States | Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $350,000 | 2007 | 2008 |
| GNo:154550554 |
Molecular toxinology of Australian Box jellyfish venoms$271,750
Funding Body: NHMRC (National Health & Medical Research Council)
| Scheme | Role |
|---|
| Project Grant | Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $271,750 | 2007 | 2010 |
| GNo:154550530 |
A randomised controlled trial of intramuscular droperidol for rapid sedation of aggressive and agitated psychostimulant-associated delirium$84,015
Funding Body: NSW Ministry of Health
| Scheme | Role |
|---|
| Drug and Alcohol Council Research Grants Program | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $84,015 | 2007 | 2008 |
| GNo:154550546 |
2005 (2 grants)
Prospective evaluation of terrestrial and marine envenoming in humans: clinical effects, predictors of severity, toxicokinetics and potential treatments$486,250
Funding Body: NHMRC (National Health & Medical Research Council)
| Scheme | Role |
|---|
| Career Development Fellowships | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $486,250 | 2005 | 2009 |
| GNo:154550522 |
A Randomised Controlled Trial of Hot Water (45°C) Immersion versus Ice Packs for Chironex fleckeri Stings$9,722
Funding Body: Emergency Medicine Research Foundation Pty Ltd
| Scheme | Role |
|---|
| Morson Taylor Research Award | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $9,722 | 2005 | 2005 |
| GNo:154550562 |
2004 (1 grants)
A randomised controlled trial of warm water versus ice packs for acute treatment of blue bottle (Physalia spp.) stings$9,651
Funding Body: Calvary Mater Newcastle
| Scheme | Role |
|---|
| Margaret Mitchell Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $9,651 | 2004 | 2005 |
| GNo:154550570 |
2003 (2 grants)
PULSE Young Medical Researcher of the Year$5,000
Funding Body: Hunter Medical Research Institute
| Project Team |
|---|
| Doctor Geoff Isbister |
| Scheme | Role |
|---|
| Research Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $5,000 | 2003 | 2003 |
| GNo:G0182734 |
North american Congress of Clinical Toxicology - 2003, Chicago, Illinois 4-9 September, 2003$2,500
Funding Body: University of Newcastle
| Project Team |
|---|
| Doctor Geoff Isbister |
| Scheme | Role |
|---|
| Travel Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $2,500 | 2003 | 2003 |
| GNo:G0183162 |
2002 (3 grants)
Development of High Performance liquid chromatography for assaying tetrodotoxin in urine and correlation with clinical features in tetrodotoxin poisoning$12,500
Funding Body: University of Newcastle
| Project Team |
|---|
| Doctor Geoff Isbister |
| Scheme | Role |
|---|
| New Staff Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $12,500 | 2002 | 2002 |
| GNo:G0182662 |
Paediatric Poisoning$5,400
Funding Body: Childrens Hospital Fund
| Scheme | Role |
|---|
| Small Grants Scheme | Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $5,400 | 2002 | 2002 |
| GNo:14937331 |
European Association of Poisons Centres and Clinical Toxicologists XXII International Congress, Lisbon Portugal, 22 - 25 May 2002$2,500
Funding Body: University of Newcastle
| Project Team |
|---|
| Doctor Geoff Isbister |
| Scheme | Role |
|---|
| Travel Grant | Chief Investigator |
| Total Amount | Funding Start | Funding Finish |
|---|
| $2,500 | 2002 | 2002 |
| GNo:G0181723 |
EditResearch Supervision
| Number of current supervisions | 4 |
|---|
| Total current UoN PhD EFTSL | 2 |
|---|
For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.
Current Supervision
| Commenced | Proposed Completion | Program | Supervisor Type | Research Title |
|---|
| 2012 | 2016 | PhD (Clinical Pharm) | Principal Supervisor | Investigation of the Toxic Effects of Venoms From Sri Lankan Snakes and the Efficacy of Antivenoms. |
| 2011 | 2019 | PhD (Medicine) | Co-Supervisor | Microparticles in Vascular Biology and Thrombosis |
| 2010 | 2014 | PhD (Medicine) | Principal Supervisor | Clinical Toxicology: Sedation of Violent and Acute Behavioural Disturbance |
| 2008 | 2016 | PhD (Clinical Pharm) | Principal Supervisor | Factors Contributing to Serotonin Toxicity |